Innovus Pharmaceuticals Announces Receipt of Marketing Authorization for Zestra in the United Arab Emirates
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company) innovuspharma.com (OTCQB:INNV) a company focusing on the commercialization of over-the-counter ("OTC") and consumer products for men's and women's health, vitality and respiratory diseases announced today that its partner Sothema Laboratories, ("Sothema") received marketing authorization for Zestra® in the United Arab Emirates (the "UAE").
View full press release